Insider Trades of KERINS PATRICK J Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date Type Tran OwnerType Shares Traded Last Price ▼ Shares Held
CVENT INC Beneficial Owner (10%) 01/16/2014 Form 4 Sell indirect 1,132,589 35.5 6,163,993
CVENT INC Beneficial Owner (10%) 01/21/2014 Form 4 Sell indirect 169,887 35.5 5,994,106
CHANNELADVISOR CORP Director 11/12/2013 Form 4 Sell indirect 1,104,241 32.37 1,661,357
EPIZYME, INC. Beneficial Owner (10%) 11/15/2013 Form 4 Buy indirect 49,500 19.3095 6,439,740
EPIZYME, INC. Beneficial Owner (10%) 11/14/2013 Form 4 Buy indirect 357,000 19.0413 357,000
DERMIRA, INC. Beneficial Owner (10%) 10/08/2014 Form 4 Buy indirect 69,112 16 3,502,922
EPIZYME, INC. Beneficial Owner (10%) 06/05/2013 Form 4 Buy indirect 400,000 15 6,033,240
LOXO ONCOLOGY, INC. Beneficial Owner (10%) 08/06/2014 Form 4 Buy indirect 230,769 13 1,789,420
ROKA BIOSCIENCE, INC. Beneficial Owner (10%) 07/22/2014 Form 4 Buy indirect 383,333 12 3,216,810
CHANNELADVISOR CORP Director 01/27/2014 Form 4 Disposition (Non Open Market) indirect 312,041 10.96 2,316,692
TRACON PHARMACEUTICALS, INC. Beneficial Owner (10%) 02/04/2015 Form 4 Buy indirect 500,000 10 1,888,474
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/27/2014 Form 4 Sell indirect 108,300 8.17 4,817,733
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/28/2014 Form 4 Sell indirect 146,800 7.8668 4,670,933
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/29/2014 Form 4 Sell indirect 11,600 7.506 4,659,333
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/12/2014 Form 4 Sell indirect 35,540 6.7583 4,926,033
SUNESIS PHARMACEUTICALS INC Beneficial Owner (10%) 08/08/2014 Form 4 Sell indirect 675,000 6.6201 4,961,573
INTERLEUKIN GENETICS INC Beneficial Owner (10%) 12/23/2014 Form 4 Buy indirect 19,868,965 0.1003 35,298,087
CHANNELADVISOR CORP Director 05/29/2013 Form 4 Acquisition (Non Open Market) indirect 2,765,599 0 2,765,599
CLOVIS ONCOLOGY, INC. Beneficial Owner (10%) 06/03/2013 Form 4 Acquisition (Non Open Market) indirect 11,399 0 11,399
CLOVIS ONCOLOGY, INC. Beneficial Owner (10%) 06/03/2013 Form 4 Disposition (Non Open Market) indirect 1,151,289 0 2,279,781

Create your free portfolio